A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

Scientific publication - Journal Article uoadl:2951634 28 Read counter

Description
Contents

Unit:

Faculty of Medicine

Title:

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

Languages of Item:

English

Abstract:

Empty abstract

Publication year:

2012

Authors:

Kastritis, Efstathios
Terpos, Evangelos
Roussou, Maria
Gavriatopoulou, Maria
Pamboukas, Constantinos
Boletis, Ioannis
Marinaki, Smaragda
Apostolou, Theofanis
Nikitas, Nikitas
Gkortzolidis, Georgios
others

Journal:

Blood, The Journal of the American Society of Hematology

Publisher:

American Society of Hematology Washington, DC

Volume:

119

Number:

Pages:

5384--5390

Main subject category:

Health Sciences

Persistent URL:

https://pergamos.lib.uoa.gr/uoa/dl/object/2951634

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

The digital material of the item is not available.